CRL vs WSR · rev $2.00B vs P/E 20, rev $160.9M
Charles River Laboratories (CRL) versus Whitestone REIT (WSR) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Whitestone REIT (WSR) is a reit - retail company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported WSR revenue for 2025-12-31 was $160.9M. Net income was $49.9M. Revenue was up 293.9% from 2024-12-31 to 2025-12-31. WSR currently screens at market cap $984.4M and trailing P/E 19.7.
CRL currently screens at market cap $7.78B. WSR currently screens at market cap $984.4M and trailing P/E 19.7.
Not investment advice. Open the CRL and WSR stock pages for the full models.
Not investment advice.